Lawrence Zenga
May 19, 2025 20:45
Atgenomix seqslab integrates NVIDIA’s Parabricks and Spark Rapids to improve precision medicine to enable extended health OMICS analysis for personalized treatment strategies.
In the evolving environment of medical care, precision medicine is the cornerstone of personalized treatment strategy. According to NVIDIA’s blog, the center of this change is Atgenomix Seqslab, a state -of -the -art platform designed to take advantage of health OMICS insights.
Calculation of health almighty data
Integration of electronic medical records (EMRS) with genomic and other Omics data will cause important calculations. The single entire entire genome sequencing (WGS) data set can exceed 300GB, and when combined with protein and metabolites, the data can reach the size of the fetabyte. This requires tremendous calculation resources and safe handling to comply with regulations such as HIPAA and GDPR.
Atgenomix Seqslab’s advanced platform
SEQSLAB solves these tasks using Nvidia Parabricks and Rapids Accelerator for Apache Spark (Spark-Rapids). This integration accelerates the processing of large genomes and EMR data so that the clinical decisions can be quickly determined. The Data Lake House function of SEQSLAB can integrate the genome information with clinical analysis to improve the decision -making process.
Genome analysis acceleration
Parabricks uses GPU acceleration to greatly reduce the time required for genome analysis. For example, you can use the NVIDIA T4 GPU, a task that takes several hours in the CPU, to complete the variation of 30x entire genome sequencing in just 10 minutes.
Revitalization of expandable data processing
Spark Rapids enhances down stream analysis by accelerating SQL queries and machine learning tasks. Education models such as XGBOOST for cancer type classification are rapidly fast due to GPU acceleration. It enables quick insight and clinical application.
Implementation of precision medical work
SEQSLAB automates the entire precision medical workflow from raw sequencing data to executable insights. The platform’s expansion and compliance preparation solutions efficiently handle large -scale data, supporting hospitals and research institutes for precise medical development.
By integrating state -of -the -art technology, atgenomix seqslab enables faster diagnosis, personalized treatment and drug discovery accelerating, changing the medical industry to achieve the ultimate goal of precision medicine to change the medical industry.
To get additional insights, visit the original NVIDIA blog.
Image Source: Shutter Stock